[en] This study investigates erythromycin toxicity toward activated sludge as a function of exposure time
and antibiotic concentration. Batch experiments were conducted and microscopic techniques ranging
from bright-field microscopy to epifluorescence and confocal laser scanning microscopy (CLSM), combined
with a fluorescent viability indicator (BacLight
®
Bacterial Viability Kit, Molecular Probes), allowed
us to study erythromycin time-kill activity. The erythromycin toxicity was observed at lower concentration
when exposure time increased. A 4 .g/L erythromycin concentration was toxic to heterotrophic
bacteria on a 5-day time exposure, and a 5 mg/L concentration inhibited nitrification. These findings
are in agreement with the microscopic studies, which showed a latency time before the lower antibiotic
concentrations began to kill bacteria. Microscope slide wells were used as micro-reactors in which
erythromycin concentration ranged from 0.1 to 1 mg/L. After 45 min there were 94% (SD 3.8) of living
bacteria in control micro-reactors, 67% (SD 3.1) in micro-reactors that contained 0.1 mg/L erythromycin
and 37% (SD 18.6) in micro-reactors that contained 1 mg/L erythromycin. CLSM allowed visualization of
isolated stained cells in the three-dimensional structure of damaged flocs
Lienert J., Güdel K., Escher B.I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environmental Science and Technology 2007, 41:4471-4478.
Focazio M.J., Kolpin D.W., Barnes K.K., Furlong E.T., Meyer M.T., Zaugg S.D., et al. A national reconnaissance for pharmaceuticals and other organic wastewater contaminants in the United States. II. Untreated drinking water sources. Science of the Total Environment 2008, 402:201-216.
Lee Y.J., Lee S.E., Lee D.S., Kim Y.H. Risk assessment of human antibiotics in Korean aquatic environment. Environmental Toxicology and Pharmacology 2008, 26:216-221.
Isidori M., Lavorgna M., Nardelli A., Pascarella L., Parrella A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Science of the Total Environment 2005, 346:87-98.
Baquero F., Martinez J.L., Canton R. Antibiotics and antibiotic resistance in water environments. Current Opinion in Biotechnology 2008, 19:260-265.
Kümmerer K. Antibiotics in the aquatic environment-a review. Part II. Chemosphere 2009, 75:435-441.
Al-Ahmad A., Haiβ A., Unger J., Brunswick-Tietze A., Wiethan J., Kümmerer K. Effects of a realistic mixture of antibiotics on resistant and nonresistant sewage sludge bacteria in laboratory-scale treatment plants. Archives of Environmental Contamination and Toxicology 2009, 2:264-273.
Amann R., Lemmer H., Wagner M. Monitoring the community structure of wastewater treatment plants: a comparison of old and new techniques. FEMS Microbiology Ecology 1998, 25:205-215.
Tomlinson T.G., Boon A.G., Trotman N.A. Inhibition of nitrification in the activated sludge process of sewage disposal. Journal of Applied Bacteriology 1966, 29(2):266-291.
Schuster A., Hädrich C., Kümmerer K. Flows of active pharmaceutical ingredients originating from health care practices on a local, regional, and nationwide level in Germany. Is hospital effluent treatment an effective approach for risk reduction?. Water, Air, and Soil Pollution 2008, 8:457-471.
Kümmerer K. Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources-a review. Chemosphere 2001, 45:957-969.
Kümmerer K. Antibiotics in the aquatic environment-a review. Part I. Chemosphere 2009, 75:417-434.
Hartmann A., Alder A.C., Koller T., Widmer R.M. Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater. Environmental Toxicology and Chemistry 1998, 17:377-382.
Larsson D.G.J., de Pedro C., Paxeus N. Effluent from drug manufactures contains extremely high levels of pharmaceuticals. Journal of Hazardous Materials 2007, 148:751-755.
Karthikeyan K.G., Meyer M.T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Science of the Total Environment 2006, 361:196-207.
Gulkowska A., Leung H.W., So M.K., Taniyasu S., Yamashita N., Yeung L.W.Y., et al. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Research 2008, 42:395-403.
Xu W., Zhang G., Li X., Zouc S., Lia P., Hua Z., et al. Occurrence and elimination of antibiotics at four sewage treatment plants in the Pearl River Delta (PRD), South China. Water Research 2007, 41:4526-4534.
Spongberg A.L., Witter J.D. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio. Science of the Total Environment 2008, 397:148-157.
Göbel A., Thomsen A., Mcardell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environmental Science and Technology 2005, 39:3981-3989.
Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environmental Science and Technology 2002, 36:1202-1211.
Da Motta M., Pons M.N., Roche N., Vivier H. Characterization of activated sludge by automated image analysis. Biochemical Engineering Journal 2001, 9:165-173.
Lopez C., Pons M.N., Morgenroth E. Evaluation of microscopic techniques (epifluorescence microscopy, CLSM, TPE-LSM) as a basis for the quantitative image analysis of activated sludge. Water Research 2005, 39:456-468.
Molecular Probes, LIVE/DEAD® BacLight™ Bacterial Viability Kits. Fluorescence Spectroscopy Protocols. Staining Bacteria with either Kit L7007 or L7012. Revised: 15 July; 2004.
Alighardashi A., Pandolfi D., Potier O., Pons M.N. Acute sensitivity of activated sludge bacteria to erythromycin. Journal of Hazardous Materials 2009, 172:685-692.
Louvet J.N., Giammarino C., Potier O., Pons M.N. Adverse effects of erythromycin on the structure and chemistry of activated sludge. Environmental Pollution 2010, 158:688-693.
Fan C., Lee P.K.H., Ng W.J., Alvarez-Cohen L., Brodie E.L., Andersen G.L., et al. Influence of trace erythromycin and erythromycin-H2O on carbon and nutrients removal and on resistance selection in sequencing batch reactors (SBRs). Environmental Biotechnology 2009, 85:185-195.
Fernández I., Mosquera-Corral A., Campos J.L., Méndez R. Operation of an Anammox SBR in the presence of two broad-spectrum antibiotics. Process Biochemistry 2009, 44:494-498.
Gião M.S., Wilks S.A., Azevedo N.F., Vieira M.J., Keevil C.W. Validation of SYTO 9/propidium iodide uptake for rapid detection of viable but noncultivable Legionella pneumophila. Microbial Ecology 2009, 58:56-62.
Chu C.P., Lee D.J., Tay J.H. Floc model and intrafloc flow. Chemical Engineering Science 2005, 60:565-575.